Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are ...

Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate ...

Researchers propose that CNDP2-mediated cooperation can be an effective and specific target for cancer treatment.

Furthermore, they have demonstrated that it is possible to reprogram other cancer cells to become dependent on this enzyme – ...

Ono Pharmaceutical has secured approval from the US Food and Drug Administration (FDA) for its kinase inhibitor Romvimza ...

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

Net sales totaled SEK 27,936 (23,118)* thousand, with a growth rate of 21%, including when adjusted for currency effects. Net sales, including the divested Antibody Business, totaled ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

When a tumor develops, it creates a structure around itself called the tumor stroma, within which blood and lymphatic vessels ...